Form D · Biotechnology
Potrero Medical, Inc.
Hayward, CA · CIK 0001609048
Offering snapshot reported May 29, 2026 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 56 Form D · investor count
- Minimum accepted
- $1.32K Reported outside-investor minimum
- First sale
- May 8, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 29, 2026 | Initial | $6,500,000 | No comparison | 56 | SEC filing |
| Sep 2, 2025 | Initial | $2,278,241 | No comparison | 29 | SEC filing |
| Oct 31, 2024 | Initial | $3,200,000 | No comparison | 6 | SEC filing |
| Apr 10, 2023 | Initial | $17,747,111 | No comparison | 99 | SEC filing |
| Oct 29, 2019 | Amendment | $17,185,962 | $5,442,994vs Jul 12, 2019 | 26 | SEC filing |
| Jul 12, 2019 | Initial | $11,742,968 | No comparison | 20 | SEC filing |
| Jul 10, 2018 | Initial | $24,642,458 | No comparison | 32 | SEC filing |
| Aug 7, 2017 | Amendment | $7,259,254 | $2,419,996vs Sep 13, 2016 | 21 | SEC filing |
| Sep 13, 2016 | Initial | $4,839,258 | No comparison | 14 | SEC filing |
| May 27, 2014 | Initial | $3,900,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $650K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-585602
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Ceros Financial Services, Inc. | 37869 |
Source: Form D, filed May 29, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sanjay Banerjee | Executive |
| Daniel Burnett | Director |
| Alan Chesler | Director |
| Christopher Dewey | Director |
| Todd Dunn | Executive |
| Maurice Ferre | Director |
| Khalid Ghafari | Executive |
| Mark Goldwasser | Director |
| David Greenberg | Director |
| Clay Heighten | Director |
| Urban Joe | Director |
| Rich Keenan | Executive |
| David Matlin | Director |
| Carter Meyer | Director |
| Frederic H. Moll | Director |
| Andrew Offer | Director |
| George Rapier | Director |
| Ram Reddy | Director |
| Ramachandra Reddy | Director |
| Mike Stansky | Director |
| Joe Urban | Director, Executive |
| Jay Watkins | Director |
| Colby Wood | Director |
| Chad Zaring | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
26142 Eden Landing Rd.
Hayward, CA, 94545
Hayward, CA, 94545